“Sizable Upside Potential”: 5 Buy-Rated Stocks Under $10 For Aggressive Investors
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” states the author of today’s…
davidgoldstein
This Biopharmaceutical Stock Could Triple From Current Levels
The biopharmaceutical stock discussed in today’s article could triple from current levels if the positive thesis of one analyst covering the stock plays out –…
10 Stocks Poised For Possible Breakouts
Today’s article highlights 10 stocks that traders may want to add to their watchlists this week, as each appears poised for a possible breakout in…
New Stocks To Watch In Tech, Biotech, Green Energy And Health & Wellness
New China stocks listed on the Nasdaq/NYSE that are involved in cloud computing, mobile apps and Internet advertising, and a life sciences company using tech…
These 4 Stocks Have Value Stock Metrics – And Momentum Stock Upside!
“These are four quality stocks to buy that have value characteristics but also appear to have the hidden potential to have momentum stock upside,” says…
New Stocks To Watch In Tech And Biotech (And Mining, Sports & Restaurants)
Tech companies involved in the software, cloud computing, mobile app and telecom sectors are among the new tech stocks to watch highlighted in today’s article,…
These 2 Healthcare Stocks That Achieved Price Highs In The Past Year May Be Best Avoided Now
Like many healthcare stocks, the two discussed in today’s article hit price highs over the past year. Unlike many healthcare stocks, however, they didn’t necessarily…
A Sober Look At This Psychedelic Stock
Amid growing acceptance of the use of psychedelic drugs for treating mental disorders, the clinical-stage biotech company featured in today’s article, which has a pipeline…
A Strong Product Pipeline, Solid Upside And Attractive Valuation Could Make This Biotech A Buy
With nine FDA-approved products and more than 30 product candidates in clinical development – including a potential COVID-19 therapeutic – the biotechnology company featured in…
Even SPAC Skeptics Are Intrigued By This One
While the contributors to today’s article are not necessarily fans of blank check special purpose acquisition companies (SPACs), they cannot help but be intrigued by…